1. Home
  2. GGB vs GKOS Comparison

GGB vs GKOS Comparison

Compare GGB & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GGB
  • GKOS
  • Stock Information
  • Founded
  • GGB 1901
  • GKOS 1998
  • Country
  • GGB Brazil
  • GKOS United States
  • Employees
  • GGB N/A
  • GKOS N/A
  • Industry
  • GGB Steel/Iron Ore
  • GKOS Medical/Dental Instruments
  • Sector
  • GGB Industrials
  • GKOS Health Care
  • Exchange
  • GGB Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • GGB 5.5B
  • GKOS 5.1B
  • IPO Year
  • GGB 1999
  • GKOS 2015
  • Fundamental
  • Price
  • GGB $2.67
  • GKOS $96.63
  • Analyst Decision
  • GGB Buy
  • GKOS Strong Buy
  • Analyst Count
  • GGB 2
  • GKOS 13
  • Target Price
  • GGB $5.00
  • GKOS $155.00
  • AVG Volume (30 Days)
  • GGB 11.4M
  • GKOS 1.0M
  • Earning Date
  • GGB 04-28-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • GGB 5.28%
  • GKOS N/A
  • EPS Growth
  • GGB N/A
  • GKOS N/A
  • EPS
  • GGB 0.35
  • GKOS N/A
  • Revenue
  • GGB $10,837,144,685.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • GGB $8.01
  • GKOS $27.84
  • Revenue Next Year
  • GGB $4.95
  • GKOS $27.99
  • P/E Ratio
  • GGB $7.35
  • GKOS N/A
  • Revenue Growth
  • GGB N/A
  • GKOS 21.85
  • 52 Week Low
  • GGB $2.27
  • GKOS $77.91
  • 52 Week High
  • GGB $4.04
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • GGB 49.73
  • GKOS 50.06
  • Support Level
  • GGB $2.49
  • GKOS $87.17
  • Resistance Level
  • GGB $2.69
  • GKOS $98.86
  • Average True Range (ATR)
  • GGB 0.12
  • GKOS 5.59
  • MACD
  • GGB 0.02
  • GKOS 1.78
  • Stochastic Oscillator
  • GGB 94.05
  • GKOS 88.89

About GGB Gerdau S.A.

Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as nails, rebar, columns, billets, slabs, tribar tutor, mechanical construction bars, reinforced steel locks. The company's geographical segment includes Brazil Operations; North America Operations; South America Operations as well as Special Steel Operations. It derives majority of the revenue from the North America Operations segment.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: